241 related articles for article (PubMed ID: 8524214)
1. Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2.
Beerli RR; Graus-Porta D; Woods-Cook K; Chen X; Yarden Y; Hynes NE
Mol Cell Biol; 1995 Dec; 15(12):6496-505. PubMed ID: 8524214
[TBL] [Abstract][Full Text] [Related]
2. An immunological approach reveals biological differences between the two NDF/heregulin receptors, ErbB-3 and ErbB-4.
Chen X; Levkowitz G; Tzahar E; Karunagaran D; Lavi S; Ben-Baruch N; Leitner O; Ratzkin BJ; Bacus SS; Yarden Y
J Biol Chem; 1996 Mar; 271(13):7620-9. PubMed ID: 8631797
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities.
Beerli RR; Hynes NE
J Biol Chem; 1996 Mar; 271(11):6071-6. PubMed ID: 8626392
[TBL] [Abstract][Full Text] [Related]
4. Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling.
Graus-Porta D; Beerli RR; Hynes NE
Mol Cell Biol; 1995 Mar; 15(3):1182-91. PubMed ID: 7532277
[TBL] [Abstract][Full Text] [Related]
5. Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors.
Bacus SS; Gudkov AV; Zelnick CR; Chin D; Stern R; Stancovski I; Peles E; Ben-Baruch N; Farbstein H; Lupu R
Cancer Res; 1993 Nov; 53(21):5251-61. PubMed ID: 8106145
[TBL] [Abstract][Full Text] [Related]
6. Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cells.
Bacus SS; Yarden Y; Oren M; Chin DM; Lyass L; Zelnick CR; Kazarov A; Toyofuku W; Gray-Bablin J; Beerli RR; Hynes NE; Nikiforov M; Haffner R; Gudkov A; Keyomarsi K
Oncogene; 1996 Jun; 12(12):2535-47. PubMed ID: 8700512
[TBL] [Abstract][Full Text] [Related]
7. ErbB kinases and NDF signaling in human prostate cancer cells.
Grasso AW; Wen D; Miller CM; Rhim JS; Pretlow TG; Kung HJ
Oncogene; 1997 Nov; 15(22):2705-16. PubMed ID: 9400997
[TBL] [Abstract][Full Text] [Related]
8. Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2.
Zhang K; Sun J; Liu N; Wen D; Chang D; Thomason A; Yoshinaga SK
J Biol Chem; 1996 Feb; 271(7):3884-90. PubMed ID: 8632008
[TBL] [Abstract][Full Text] [Related]
9. A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor.
Tzahar E; Waterman H; Chen X; Levkowitz G; Karunagaran D; Lavi S; Ratzkin BJ; Yarden Y
Mol Cell Biol; 1996 Oct; 16(10):5276-87. PubMed ID: 8816440
[TBL] [Abstract][Full Text] [Related]
10. Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells.
Marte BM; Jeschke M; Graus-Porta D; Taverna D; Hofer P; Groner B; Yarden Y; Hynes NE
Mol Endocrinol; 1995 Jan; 9(1):14-23. PubMed ID: 7760847
[TBL] [Abstract][Full Text] [Related]
11. Heregulins and the ErbB-2/3/4 receptors in gliomas.
Westphal M; Meima L; Szonyi E; Lofgren J; Meissner H; Hamel W; Nikolics K; Sliwkowski MX
J Neurooncol; 1997 Dec; 35(3):335-46. PubMed ID: 9440030
[TBL] [Abstract][Full Text] [Related]
12. ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms.
Tzahar E; Levkowitz G; Karunagaran D; Yi L; Peles E; Lavi S; Chang D; Liu N; Yayon A; Wen D
J Biol Chem; 1994 Oct; 269(40):25226-33. PubMed ID: 7929212
[TBL] [Abstract][Full Text] [Related]
13. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer.
Karunagaran D; Tzahar E; Beerli RR; Chen X; Graus-Porta D; Ratzkin BJ; Seger R; Hynes NE; Yarden Y
EMBO J; 1996 Jan; 15(2):254-64. PubMed ID: 8617201
[TBL] [Abstract][Full Text] [Related]
14. Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulin-like growth factor-I in human mammary epithelial cells.
Ram TG; Kokeny KE; Dilts CA; Ethier SP
J Cell Physiol; 1995 Jun; 163(3):589-96. PubMed ID: 7775601
[TBL] [Abstract][Full Text] [Related]
15. ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network.
Pinkas-Kramarski R; Shelly M; Guarino BC; Wang LM; Lyass L; Alroy I; Alimandi M; Kuo A; Moyer JD; Lavi S; Eisenstein M; Ratzkin BJ; Seger R; Bacus SS; Pierce JH; Andrews GC; Yarden Y
Mol Cell Biol; 1998 Oct; 18(10):6090-101. PubMed ID: 9742126
[TBL] [Abstract][Full Text] [Related]
16. ErbB-3 mediates differential mitogenic effects of NDF/heregulin isoforms on mouse keratinocytes.
Marikovsky M; Lavi S; Pinkas-Kramarski R; Karunagaran D; Liu N; Wen D; Yarden Y
Oncogene; 1995 Apr; 10(7):1403-11. PubMed ID: 7731691
[TBL] [Abstract][Full Text] [Related]
17. Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro.
Lyne JC; Melhem MF; Finley GG; Wen D; Liu N; Deng DH; Salup R
Cancer J Sci Am; 1997; 3(1):21-30. PubMed ID: 9072304
[TBL] [Abstract][Full Text] [Related]
18. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line.
Ethier SP; Kokeny KE; Ridings JW; Dilts CA
Cancer Res; 1996 Feb; 56(4):899-907. PubMed ID: 8631031
[TBL] [Abstract][Full Text] [Related]
19. Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships.
Peles E; Ben-Levy R; Tzahar E; Liu N; Wen D; Yarden Y
EMBO J; 1993 Mar; 12(3):961-71. PubMed ID: 8096177
[TBL] [Abstract][Full Text] [Related]
20. Activity-dependent regulation of Neu differentiation factor/neuregulin expression in rat brain.
Eilam R; Pinkas-Kramarski R; Ratzkin BJ; Segal M; Yarden Y
Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1888-93. PubMed ID: 9465112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
